59 South said:

---

Same here. I have a couple small buys at 3.00 and 2.36 and then a big one at 2.16.

---

I'm still way in the red. I bought way too much in the 3s while I was still learning. Live and learn. Now I'm just averaging down.

badharambe said:

---

Yep. I've been adding to it, its low looks like .26. I'm At 2k shares with .38 average. Looking to add more but waiting for a change to uptrend, this might be a long, long term hold but a decently safe hold (my opinion, do your own DD)

---

Sooooo NVCN has gone through major dilution in order to have cash on hand to continue their current operations.

Currently, they are not in compliance with the stock price requirements and will undoubtedly undergo a reverse stock split in the coming months. Sadly, this is proof of timing being everything as my investment in a great product more than likely won't pan out as I didn't pick it at the right time.

Going in on NKTR (Nektar Therapeutics).
Usually uneasy with biotech, but this is darn cheap.

EDIT: Changed my mind after reading more about it

AVEO just spiked $0.10 at the last minute of trading today

AKAO just tanked 16%.

Achaogen (AKAO), a biopharmaceutical company, said Tuesday the U.S. Food and Drug Administration (FDA) has approved ZEMDRI (plazomicin) for adults with complicated urinary tract infections, including pyelonephritis, caused by certain Enterobacteriaceae in patients who have limited or no alternative treatment options.


However, AKAO shares were down 10% after resuming trade after the company said it received a complete response letter (CRL) saying its study does not provide substantial evidence of effectiveness of plazomicin to treat bloodstream infection.


The company said it intends to meet with the FDA to determine whether there is a feasible resolution to address the CRL.

Where does it go from here? Surely investors will be back into it seeing that it got approval for one drug.

Update 19%. Holy cow

Down 25%. Anyone buying today?

Technically, it just blew through that lower support level of around $10...so yeah I'll pass

Seor Chang said:

---

Down 25%. Anyone buying today?

---

I'm not catching that falling knife. I'll give it a couple days before deciding. It's just weird that it's down, even after they got FDA approval for UTI, but knew it was going to be a struggle to get BSI approval. Shorts freaking out IMO. Hopefully in a month or so it'll be back to normal.

Holy... $8.75 now

I'm not sure where the reversal will be. I'm sure there will be one, but just don't know where. There was more volume just now, green side, thann has been all morning, so maybe we're close.

AKAO and NKTR falling like rocks today. Making my portfolio look like doodoo

A CRL was worst case scenario for AKAO. I would not be buying here. There is no upside in this name for quite some time.

Missed this on NKTR yesterday. FYI for other share holders.

https://finance.yahoo.com/news/shareholder-alert-purcell-julie-lefkowitz-113400382.html?.tsrc=applewf

IS NKTR a sell?

I'm going to hold to see if it recovers. I'm a novice so I have no idea with the investigation. This is a first to me.

They're common with publicly traded companies. The only people that win are the lawyers. Insurance typically covers the cost.

AKAO seems to have bounced a bit. Starting to settle with very little volume. What does it do from here? Personally I think this is oversold and we could see a bullish reversal. The BSI was likely to not be approved, and it's main use is UTI. I think the shorts were overly optimistic or don't realize this aspect.

I could be wrong. Any other thoughts?

AKAO down 6+% today to $8.32

Put in a stop on NKTR at $45. FDA decision on NKTR-181 is due any day, so this stock is likely to +/- $20 very soon. Which direction is anyone's guess.

AVEO down 8% and still going today

Same... I'm hoping for the +. My bio portfolio has been hammered lately.

Plenty of dips to buy right now.



I'm actually up slightly today, but this has been a rough week.

AVEO testing that resistance line at $2.40 or so

Rgls plummeting. Woof

https://finance.yahoo.com/news/regulus-announces-strategic-corporate-restructuring-210000191.html?.tsrc=applewf

AVEO up 6% after hours and 9% since this morning.

Anyone know what is driving this?

gougler08 said:

---

Anyone know what is driving this?

---

Speculation on a new EU recommendation.

https://www.scottishmedicines.org.uk/medicines-advice/tivozanib-fotivda-fullsubmission-133518/

I picked up another 60,000 shares of OBMP on Friday. Looking forward to the future!

Gabster43213 said:

---

I picked up another 60,000 shares of OBMP on Friday. Looking forward to the future!

---

Can you screen shot your OBMP position?

cowboy,

why do you ask? How much do you own?

That's about $1560. Not anything to lie about.

Gabster43213 said:

---

cowboy,

why do you ask? How much do you own?

---

I own zero, but I'm genuinely curious how many you own. Throughout this thread you've mentioned 7-8 times buying more OBMP and you've been investing in this company for years.

I'd like to get on board with you, but will feel more comfortable if your can provide more information. TIA

Regardless of what Gabster or anyone else owns or believes, I would go into it assuming that you'll probably never get that money back. There is a pot of gold at the end of the knife's edge path, but on one side of the path is financial insolvency and on the other is poor phase 2 results.

The odds favor either bankruptcy or a really cheap buyout, that's why it's down to 2 1/2 cents per share and management has diluted the equity dramatically over the last few months. Based on a reading of the financial statements, their governance and managerial competence are suspect.

That said, the medical technology could be a gamechanger in the treatment of one of the most common cancers. If it works, the equity has the potential to go way up (100x). They are entering phase 2 trials now.

I have a little myself, but I fully expect to wake up one morning this year to find that selling out won't even cover the transaction fee.

Ulrich,

What range of price target are you talking about when you refer to a "really cheap buyout" for OBMP?